Sponsor:
Yale University
Code:
NCT05786417
Conditions
Angina
Stable Ischemic Heart Disease
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Clinician Discretion
Beta blocker
Calcium channel blocker
Brief summary:
Conditions
Angina
Stable Ischemic Heart Disease
Study ID
NCT05786417
Start date
May 10, 2023
Status verified date
Apr, 2026
Completion date
May 30, 2027
Anticipated
Primary completion date
May 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Enrollment
741 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Beta-Blockers (BB) Therapy
experimental: Calcium Channel Blockers (CCB) Therapy
Interventions
Clinician Discretion
Beta blocker
Calcium channel blocker
Primary outcome measure
Central contacts
Locations
Yale School of Medicine
Recruiting
New Haven, Connecticut, United States, 06520
Wellstar Research Institute
Recruiting
Marietta, Georgia, United States, 30060
Cook County Health
Recruiting
Chicago, Illinois, United States, 60612
Brigham and Women's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Mt. Sinai Health System
Recruiting
New York, New York, United States, 10029
Nirvana Integrative Medicine
Recruiting
New York, New York, United States, 10469
Duke University, School of Medicine
Recruiting
Durham, North Carolina, United States, 27710
Inova Health Care Services
Recruiting
Fairfax, Virginia, United States, 22033
Sponsor
Yale University
Last update posted
Apr 7, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Yale University on 2026-04-07.